Lessons Learnt during the COVID-19 Pandemic: For Patients with End-Stage Renal Disease, We Should Prioritize Home-Based Treatment and Telemedicine

Giuliano Brunori, Gianpaolo Reboldi, Filippo Aucella, Giuliano Brunori, Gianpaolo Reboldi, Filippo Aucella

Abstract

Backgrounds: The recent coronavirus disease 2019 (CO-VID-19) pandemic has placed worldwide health systems and hospitals under pressure, and so are the renal care models. This may be a unique opportunity to promote and expand alternative models of health-care delivery in patients undergoing renal replacement therapies.

Summary: Despite the high risk of acquiring communicable diseases when undergoing in-centre treatments, only a small proportion of patients are currently being treated with home therapies. Recent data provided by the Italian Society of Nephrology (SIN), the REIN French Registry and the Wuhan Hemodialysis Quality Control Center clearly show that patients receiving hospital-based treatment have a 3- to 4-fold greater risk of infection, and a subsequent fatality proportion between 21 and 34%. On the other hand, home-based therapy can be managed remotely, there is little or no need for transport to and from the hospital, and it is less expensive. Besides, the digital revolution in health care with the development of virtual care systems can make home dialysis with telehealth a cost-effective solution for both patients and health-care providers. Such a transition would require specific training for physicians and health-care professionals and a functional re-organization of dialysis centres to improve the skills and expertise in caring for patients at home.

Conclusion: The need for more widespread home treatment is the main lesson learnt by nephrologists by the COVID-19 pandemic.

Keywords: Coronavirus disease 2019; Dialysis; Home treatment; Telemedicine.

Conflict of interest statement

The authors have no conflicts of interest to declare.

© 2021 The Author(s) Published by S. Karger AG, Basel.

References

    1. Reperant LA, Cornaglia G, Osterhaus AD. The importance of understanding the human-animal interface: from early hominins to global citizens. Curr Top Microbiol Immunol. 2013;365:49–81.
    1. World Health Organization Coronavirus disease (COVID-19) pandemic. 2020. Available from: Accessed 2020 Apr 23.
    1. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 May;97((5)):829–38.
    1. Karopadi AN, Mason G, Rettore E, Ronco C. Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant. 2013 Oct;28((10)):2553–69.
    1. Rigoni M, Torri E, Nollo G, Zarantonello D, Laudon A, Sottini L, et al. Survival and time-to-transplantation of peritoneal dialysis versus hemodialysis for end-stage renal disease patients: competing-risks regression model in a single Italian center experience. J Nephrol. 2017 Jun;30((3)):441–7.
    1. Wong B, Ravani P, Oliver MJ, Holroyd-Leduc J, Venturato L, Garg AX, et al. Comparison of patient survival between hemodialysis and peritoneal dialysis among patients eligible for both modalities. Am J Kidney Dis. 2018 Mar;71((3)):344–51.
    1. Wares JR, Lawson B, Shemin D, D'Agata EM. Evaluating infection prevention strategies in out-patient dialysis units using agent-based modeling. PLoS One. 2016;11((5)):e0153820.
    1. Jadoul M, Bieber BA, Martin P, Akiba T, Nwankwo C, Arduino JM, et al. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int. 2019 Apr;95((4)):939–47.
    1. Chen TH, Wen YH, Chen CF, Tan AC, Chen YT, Chen FY, et al. The advantages of peritoneal dialysis over hemodialysis during the COVID-19 pandemic. Semin Dial. 2020 Sep;33((5)):369–71.
    1. International Society for Peritoneal Dialysis Strategies regarding COVID-19 in PD patients. 2020. Available from: Accessed 2020 Sep 15.
    1. Wilkie M, Davies S. Peritoneal dialysis in the time of COVID-19. Perit Dial Int. 2020 Jul;40((4)):357–8.
    1. Quintaliani G, Reboldi G, Di Napoli A, Nordio M, Limido A, Aucella F, et al. Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the italian society of nephrology. J Nephrol. 2020 Aug;33((4)):725–36.
    1. Xiong F, Tang H, Liu L, Tu C, Tian JB, Lei CT, et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in wuhan, China. J Am Soc Nephrol. 2020 Jul;31((7)):1387–97.
    1. Cecile C, Florian B, Carole A, Clemence B, Philippe B, Francois C, et al. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the french national cohort of dialysis patients. Kidney Int. 2020 Aug 25;98((6)):1519–29.
    1. COVID-19 Treatment Guidelines Panel Coronavirus disease 2019 (COVID-19) treatment guidelines. Available form: Accessed 2020 Oct 15.
    1. Perna AF, Capolongo G, Trepiccione F, Simeoni M, Zacchia M, Ingrosso D. COVID-19, low-molecular-weight heparin, and hemodialysis. Kidney Blood Press Res. 2020;45((3)):357–62.
    1. Karopadi AN, Mason G, Rettore E, Ronco C. The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective. Nephrol Dial Transplant. 2014 Apr;29((4)):885–92.
    1. Agarwal S, Wilkie M. Remote patient management in peritoneal dialysis: opportunities and challenges. Contrib Nephrol. 2019;197:54–64.
    1. Jeffs L, Jamieson T, Saragosa M, Mukerji G, Jain AK, Man R, et al. Uptake and scalability of a peritoneal dialysis virtual care solution: qualitative study. JMIR Hum Factors. 2019 Apr 16;6((2)):e9720.
    1. Scarpioni R, Manini A, Chiappini P. Remote patient monitoring in peritoneal dialysis helps reduce risk of hospitalization during covid-19 pandemic. J Nephrol. 2020 Aug 11;:1–2.
    1. Keesara S, Jonas A, Schulman K. Covid-19 and health care's digital revolution. N Engl J Med. 2020 Jun 4;382((23)):e82.
    1. UK Renal Association COVID-19: checklist and guidance for management of peritoneal dialysis programmes. Available from: Accessed 2020 Sep 14.
    1. La Milia V, Bacchini G, Bigi MC, Casartelli D, Cavalli A, Corti M, et al. COVID-19 outbreak in a large hemodialysis center in lombardy, Italy. Kidney Int Rep. 2020 Jul;5((7)):1095–9.
    1. Briggs V, Davies S, Wilkie M. International variations in peritoneal dialysis utilization and implications for practice. Am J Kidney Dis. 2019 Jul;74((1)):101–10.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa